Literature DB >> 16351679

Thyroid cancer review 2: management of differentiated thyroid cancers.

P Nix1, A Nicolaides, A P Coatesworth.   

Abstract

This is the second review article on thyroid cancer dealing with the common differentiated types that comprise 90% of thyroid cancers. Despite clinical management guidelines offered by a number of organisations including the British Association of Otolaryngologists and Head and Neck Surgeon, The British Thyroid Association, The American Association Of Endocrinologists, The American Thyroid Association and the National Cancer Centre Network, debate regarding the management of differentiated thyroid cancer continues. This is because of the absence of good quality research evidence as a consequence of the natural history of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351679     DOI: 10.1111/j.1368-5031.2005.00672.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.

Authors:  Longxing Cao; Zhongyong Wang; Jiawei Ma; Jinsheng Chen; Haojiang Zhu; Xiaohua Zhou; Qing Zhu; Jun Dong; Qing Lan; Qiang Huang
Journal:  Ann Transl Med       Date:  2016-12

2.  Epithelial-to-mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients.

Authors:  Deyu Li; Na Li; Ying Ding
Journal:  Mol Clin Oncol       Date:  2022-08-01

3.  MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma.

Authors:  Wen-Jing Zhang; Bing Song; Tao Yang
Journal:  Cancer Manag Res       Date:  2019-12-23       Impact factor: 3.989

Review 4.  Thyroid nodule as a first manifestation of Hodgkin lymphoma-report of two cases and literature review.

Authors:  Ewelina Szczepanek-Parulska; Malgorzata Szkudlarek; Przemyslaw Majewski; Jan Breborowicz; Marek Ruchala
Journal:  Diagn Pathol       Date:  2013-07-15       Impact factor: 2.644

5.  Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.

Authors:  Bing-Feng Chu; Yi-Yu Qin; Sheng-Lai Zhang; Zhi-Wei Quan; Ming-Di Zhang; Jian-Wei Bi
Journal:  Chin Med J (Engl)       Date:  2016-07-05       Impact factor: 2.628

6.  Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy.

Authors:  Yi Zhang; Mei Long; Peng Huang; Huaming Yang; Shi Chang; Yuehua Hu; Aidong Tang; Linfeng Mao
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.